Comparative Study of Tongxinluo Capsules and Sordi in Treatment of Patients with Silent Myocardial Ischemia
Abstract：Objective: To observe the effect of Tongxinluo Capsules(TXLC)in treating silent myocardial ischemia (SMI)of coronary artery disease. Methods:The effect of oral TXLC and Sordi were compared with those of placebo in 138 patients with coronary artery disease and SMI. Patients performed ambulatory electrocardiographic monitoring and bicycle ergometic exercise, after 8 weeks periods treatment of 4 pills, three times daily, 10～15mg Sordi, three times daily, and placebo. All drugs were given double blind and randomly. Results:TXLC not only appeared to be more effective than Sordi in reducing the number and duration of SMI, but also increasing exercise duration and delaying time of exercise angina or peak effort(P＜0.01). Conclusion:TXLC is a more effective drug in treating coronary artery disease and SMI.
Machine-generated Keywords：
Publication Date：2001-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 49-51 )